Category: Cannabis Studies

Peer-reviewed studies covering cannabis and cannabis compounds.

Epigenetic “Switch” May Help Breeders Boost Hemp Flavonoids and Cannabinoids, Study Finds

A study in Frontiers in Plant Science reports that “chromatin opening”, a form of epigenetic regulation that helps control whether genes are easy or hard to activate, may play a central role in why some cannabis varieties produce more flavonoids and cannabinoids than others.

Continue reading

Over 80% of Hemp-Derived CBD Products Are Inaccurately Labeled, Many Have No CBD, Johns Hopkins Study Finds

A study published by Cannabis & Cannabinoid Research found that most hemp-derived CBD products sold as haircare items, cosmetics, and foods or drinks did not match what their labels claimed, including products that said they were verified by third-party testing.

Continue reading

Study: Maternal Marijuana Use Not Linked to Retinopathy of Prematurity in Preterm Infants

A large study published in the Journal of American Association for Pediatric Ophthalmology and Strabismus found that preterm infants born to mothers with a diagnosed marijuana use disorder were no more or less likely to develop retinopathy of prematurity (ROP) than those born to mothers without such a diagnosis.

Continue reading

Study Published in Canadian Journal of Pain Finds Medical Marijuana Linked to Improvements in Pain, Mental Health and Quality of Life

A study published by the Canadian Journal of Pain reports that patients with chronic pain who used medical marijuana experienced measurable improvements in pain-related outcomes, mental health indicators and overall quality of life over a 24-week period.

Continue reading

Study Finds CBD May Support Bone Formation, Strength, and Healing Through Multiple Biological Pathways

A new review published in Biomedicines is adding to the growing body of research suggesting that cannabidiol (CBD) could play a meaningful role in bone health. Conducted by researchers from Universiti Kebangsaan Malaysia, the scoping review examined 24 original studies exploring how CBD affects bone-related outcomes across a range of experimental models.

Continue reading

Study: Full-Spectrum CBD Extract Reduced Meth Relapse-Like Behavior Better than CBD Alone

A study published by the journal Progress in Neuro-Psychopharmacology and Biological Psychiatry found that a full-spectrum CBD extract reduced relapse-like methamphetamine seeking and meth-triggered hyperactivity in an animal model better than CBD alone.

Continue reading

Study: Combining CBD and CBG Cuts Effective CBD Seizure Dose in Half in Standard Epilepsy Model

New research published in Basic & Clinical Pharmacology & Toxicology by scientists at the University of Toronto found that the non-psychoactive cannabinoids cannabidiol (CBD) and cannabigerol (CBG) both suppress seizures on their own and, when combined, significantly reduce the amount of CBD needed to achieve seizure protection.

Continue reading

Study: CBD Protects Newborn Brain Cells From Oxygen Deprivation by Blocking Ferroptosis Pathway

In a study being published in the March issue of Phytomedicine and published online ahead of print, CBD was found to protect newborn brain cells from one of the most damaging effects of oxygen deprivation: a form of cell death known as ferroptosis.

Continue reading

Study: Recreational and Medical Marijuana Laws Linked to 9–11% Drop in Daily Opioid Misuse Among People Who Inject Drugs

A study published in the journal Drug and Alcohol Dependence by researchers from Boston University School of Public Health, Emory University, Johns Hopkins University, and Florida State University found that states with both medical and recreational marijuana laws experienced measurable reductions in daily opioid misuse among people who inject drugs (PWID), a population at the …

Continue reading

Study: Cannabigerorcinic Acid (CBGOA) Shows Neuroprotective Effects in Human Cell Model of Stroke

New research published in the Journal of Cannabis Research and conducted by scientists at the University of Rhode Island has identified a little-known cannabinoid, cannabigerorcinic acid (CBGOA), as a potential neuroprotective compound in the context of stroke.

Continue reading